Addiction News and Research

RSS

Essential Learning announces new partnership with Hazelden

Essential Learning, the leading provider of e-learning solutions to the behavioral health and human service industries, is pleased to announce a new partnership with Hazelden, a nonprofit organization for addiction treatment and publisher of treatment, behavioral health and youth violence educational resources.

27 Aug 2012

Roundup: Rate regulation on Calif.'s 2014 ballot; Ga. state workers facing health premium hike; Kan. Medicaid overhaul recruiting providers

An initiative that would bring health insurance rate regulation to California has qualified for the November 2014 ballot, setting the stage for a vigorous and costly battle between insurers and consumer groups. The measure, sponsored by Consumer Watchdog, would give the state insurance commissioner the power to deny certain premium increases if they are deemed excessive.

26 Aug 2012

Electronic cigarettes far less harmful and may be beneficial to health

Smoking is the most preventable risk factor for cardiac and lung disease and is expected to cause 1 billion deaths during the 21st century. Electronic cigarettes have been marketed in recent years as a safer habit for smokers, with several millions of people already using them worldwide.

26 Aug 2012

Prescription drug monitoring systems alert abuse

Electronic prescription monitoring programs may significantly improve drug-abuse detection and could alert clinicians to “doctor shopping,” say researchers.

24 Aug 2012

Studies raise possibility of new DBS approaches to treat obesity

Scientific advances in understanding the "addiction circuitry" of the brain may lead to effective treatment for obesity using deep brain stimulation (DBS), according to a review article in the August issue of Neurosurgery, official journal of the Congress of Neurological Surgeons.

21 Aug 2012

Enrollment complete in BDSI's pivotal pharmacokinetic study of BNX for opioid dependence

BioDelivery Sciences International, Inc. announced that enrollment and the clinical portion of the pivotal pharmacokinetic study for BEMA Buprenorphine/Naloxone (BNX) for the treatment of opioid dependence has been completed.

20 Aug 2012

Electronic PMP use may have impact on demand for drug treatment programs, painkiller abuse

A Rhode Island Hospital researcher has found that the use of electronic prescription drug monitoring programs (PMPs) may have a significant impact on the demand for drug treatment programs and how prescribers detect and respond to abuse of painkillers.

17 Aug 2012

U.S. FDA warns of post-surgery codeine deaths in children

The U.S. Food and Drug Administration today issued a Drug Safety Communication concerning three children who died and one child who experienced a non-fatal but life-threatening case of respiratory depression after taking the pain reliever codeine following surgery to remove tonsils (tonsillectomy) and/or adenoids (adenoidectomy).

16 Aug 2012

Study tracks effects of heavy PAE on growth and body composition throughout childhood

Although studies of alcohol's effects on fetal growth have consistently demonstrated deficits that persist through infancy, the data on long-term postnatal growth from human studies have been inconsistent. A new study of the effects of heavy prenatal alcohol exposure (PAE) on growth and body composition throughout childhood has found growth restrictions that persist through to nine years of age, as well as a delay in weight gain during infancy, both of which were exacerbated by iron deficiency.

16 Aug 2012

Brain changes can occur after long-term methadone treatment

Long-term methadone treatment can cause changes in the brain, according to recent studies from the Norwegian Institute of Public Health. The results show that treatment may affect the nerve cells in the brain. The studies follow on from previous studies where methadone was seen to affect cognitive functioning, such as learning and memory.

16 Aug 2012

Addiction to morphine and heroin can be blocked via brain's immune response

In a major breakthrough, an international team of scientists has proven that addiction to morphine and heroin can be blocked, while at the same time increasing pain relief.

15 Aug 2012

Johns Hopkins CIDR receives NIH contract to study genetic diseases

The Johns Hopkins Center for Inherited Disease Research (CIDR) program contract, which provides up to $101 million in research funding from the National Institutes of Health (NIH) to study the genetic contribution to human diseases, has been renewed for another five years.

13 Aug 2012

Scientists discover why major depression or chronic stress can cause loss of brain mass

Major depression or chronic stress can cause the loss of brain volume, a condition that contributes to both emotional and cognitive impairment. Now a team of researchers led by Yale scientists has discovered one reason why this occurs - a single genetic switch that triggers loss of brain connections in humans and depression in animal models.

13 Aug 2012

IRIN examines administration of methadone as treatment for people who inject drugs in Bangladesh

"Methadone treatment is proving to be the most efficient way to wean people in Bangladesh from addiction to buprenorphine, a pharmaceutical drug, and health experts say it should be expanded to reach thousands more drug users to prevent the spread of HIV," IRIN reports.

10 Aug 2012

Two-drug combination helps combat cocaine addiction

A combination of two existing pharmaceutical drugs may soon be used to treat cocaine addiction, findings from an animal study in Science Translational Medicine suggest.

10 Aug 2012

Scientists develop new way to study role of GABA-A receptors in various disorders

A new way to study the role of a critical neurotransmitter in disorders such as epilepsy, anxiety, insomnia, depression, schizophrenia, and alcohol addiction has been developed by a group of scientists led by Gong Chen, an associate professor of biology at Penn State University.

9 Aug 2012

Combination of two existing pharmaceutical drugs shows promise against cocaine addiction

A fine-tuned combination of two existing pharmaceutical drugs has shown promise as a potential new therapy for people addicted to cocaine—a therapy that would reduce their craving for the drug and blunt their symptoms of withdrawal.

9 Aug 2012

First study to examine relationship of risky content in alcohol ads to youth exposure

The content of alcohol ads placed in magazines is more likely to be in violation of industry guidelines if the ad appears in a magazine with sizable youth readership, according to a new study from the Center on Alcohol Marketing and Youth (CAMY) at the Johns Hopkins Bloomberg School of Public Health. Published in the Journal of Adolescent Health, the study is the first to measure the relationship of problematic content to youth exposure, and the first to examine risky behaviors depicted in alcohol advertising in the past decade.

9 Aug 2012

Lightlake announces final data from naloxone nasal spray Phase II study on Binge Eating Disorder

Lightlake Therapeutics Inc., an early stage biopharmaceutical company developing modern addiction treatments based on its expertise using opioid antagonists, announced today compelling final data from a Phase II study of the Company's proprietary opioid antagonist naloxone nasal spray treatment for patients with Binge Eating Disorder (BED).

9 Aug 2012

Plain packaging of cigarettes may help draw attention of adolescent smokers to health warnings

New research published online in the scientific journal Addiction shows that plain packaging (requiring cigarettes to be packaged in standard packages without attractive designs and imagery) may help to draw the attention of some adolescent smokers to the health warnings on the package. If so, this may in turn deter young smokers from continuing to smoke.

8 Aug 2012

Addiction News and Research

Essential Learning announces new partnership with Hazelden

Roundup: Rate regulation on Calif.'s 2014 ballot; Ga. state workers facing health premium hike; Kan. Medicaid overhaul recruiting providers

Electronic cigarettes far less harmful and may be beneficial to health

Prescription drug monitoring systems alert abuse

Studies raise possibility of new DBS approaches to treat obesity

Enrollment complete in BDSI's pivotal pharmacokinetic study of BNX for opioid dependence

Electronic PMP use may have impact on demand for drug treatment programs, painkiller abuse

U.S. FDA warns of post-surgery codeine deaths in children

Study tracks effects of heavy PAE on growth and body composition throughout childhood

Brain changes can occur after long-term methadone treatment

Addiction to morphine and heroin can be blocked via brain's immune response

Johns Hopkins CIDR receives NIH contract to study genetic diseases

Scientists discover why major depression or chronic stress can cause loss of brain mass

IRIN examines administration of methadone as treatment for people who inject drugs in Bangladesh

Two-drug combination helps combat cocaine addiction

Scientists develop new way to study role of GABA-A receptors in various disorders

Combination of two existing pharmaceutical drugs shows promise against cocaine addiction

First study to examine relationship of risky content in alcohol ads to youth exposure

Lightlake announces final data from naloxone nasal spray Phase II study on Binge Eating Disorder

Plain packaging of cigarettes may help draw attention of adolescent smokers to health warnings

Achieving and maintaining ISO/IEC 27001 and BS 10012 certifications

Expanding research and clinical options for children with cancer

Examining how pain could play a direct protective role in the gut

Latest News